NASDAQ:OSA ProSomnus (OSA) Stock Price, News & Analysis → Missed Nvidia? Don't Worry… (From Behind the Markets) (Ad) Free OSA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.03▼$0.0450-Day Range$0.02▼$0.6652-Week Range$0.35▼$5.25Volume1,183 shsAverage Volume65,686 shsMarket Capitalization$478,335.00P/E RatioN/ADividend YieldN/APrice Target$2.33 Stock AnalysisStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesOwnershipShort InterestTrends Get ProSomnus alerts: Email Address Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About ProSomnus Stock (NASDAQ:OSA)ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to sleep dentists, sleep physicians, primary care providers, otolaryngologists, and other integrated healthcare service providers through a direct sales force. ProSomnus, Inc. is headquartered in Pleasanton, California.Read More Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here OSA Stock News HeadlinesMay 13, 2024 | finance.yahoo.comProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual MeetingMay 9, 2024 | finance.yahoo.comFour Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical DevicesMay 9, 2024 | markets.businessinsider.comProSomnus Sleep Technologies Takes Strategic Action to Position Company for Long-Term SuccessApril 20, 2024 | finance.yahoo.comProSomnus, Inc. (OSA) Interactive Stock Chart - Yahoo FinanceApril 17, 2024 | msn.comProSomnus (OSA) Price Target Increased by 38.89% to 2.55March 31, 2024 | finanznachrichten.deProSomnus Sleep Technologies, Inc.: ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial ResultsMarch 30, 2024 | finance.yahoo.comProSomnus, Inc. Common Stock (NASDAQ:OSA) Q4 2023 Earnings Call TranscriptMarch 28, 2024 | investorplace.comOSA Stock Earnings: ProSomnus Misses EPS, Beats Revenue for Q4 2023March 27, 2024 | finance.yahoo.comQ4 2023 Prosomnus Inc Earnings CallMarch 26, 2024 | globenewswire.comProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial ResultsMarch 15, 2024 | globenewswire.comProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update CallFebruary 23, 2024 | msn.comProSomnus reports pilot study data for remote OSA monitoring deviceFebruary 23, 2024 | benzinga.comTop 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)February 22, 2024 | finance.yahoo.comProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep ApneaFebruary 22, 2024 | globenewswire.comProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep ApneaFebruary 20, 2024 | finance.yahoo.comProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024January 30, 2024 | finance.yahoo.comProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDAJanuary 29, 2024 | finance.yahoo.comProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA DevicesJanuary 23, 2024 | benzinga.comProSomnus Stock (NASDAQ:OSA) Dividends: History, Yield and DatesJanuary 8, 2024 | finance.yahoo.comProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep ApneaDecember 20, 2023 | morningstar.comProSomnus Inc OSADecember 19, 2023 | msn.comWhy Is Sleep Devices Focused ProSomnus Stock Soaring Today?December 19, 2023 | finance.yahoo.comProSomnus Treatment for Sleep Apnea Effective, Study ShowsDecember 19, 2023 | finance.yahoo.comData Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance DevicesNovember 12, 2023 | benzinga.comProSomnus Stock (NASDAQ:OSA), Analyst Ratings, Price Targets, PredictionsSee More Headlines Receive OSA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ProSomnus and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:OSA CUSIPN/A CIK1934064 Webwww.ProSomnus.com Phone844-537-5337FaxN/AEmployees136Year FoundedN/APrice Target and Rating Average Stock Price Target$2.33 High Stock Price Target$4.00 Low Stock Price Target$1.00 Potential Upside/Downside+8,233.3%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($1.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-24,090,000.00 Net Margins-87.14% Pretax Margin-87.14% Return on EquityN/A Return on Assets-106.30% Debt Debt-to-Equity RatioN/A Current Ratio1.00 Quick Ratio0.86 Sales & Book Value Annual Sales$27.65 million Price / Sales0.02 Cash FlowN/A Price / Cash FlowN/A Book Value($2.33) per share Price / Book-0.01Miscellaneous Outstanding Shares17,394,000Free Float16,055,000Market Cap$487,032.00 OptionableNot Optionable Beta0.21 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Leonard Liptak (Age 49)Co-Founder, CEO & Director Comp: $965.35kMr. Sung Kim (Age 42)Co-Founder & CTO Comp: $454.63kMs. Laing F. RikkersCo-founder & Executive ChairmanMr. Brian B. Dow (Age 55)CFO & Corporate Secretary Dr. John E. Remmers M.D.Chief ScientistMs. Heather WhalenVice President of Global Marketing ServicesDr. Shouresh Charkhandeh D.D.S.Global Scientific Committee ChairMore ExecutivesKey CompetitorsBluejay DiagnosticsNASDAQ:BJDXAcutus MedicalNASDAQ:AFIBAethlon MedicalNASDAQ:AEMDMotus GINASDAQ:MOTSProSomnusNASDAQ:OSAPView All Competitors OSA Stock Analysis - Frequently Asked Questions Should I buy or sell ProSomnus stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ProSomnus in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" OSA shares. View OSA analyst ratings or view top-rated stocks. What is ProSomnus' stock price target for 2024? 3 Wall Street analysts have issued 1 year price objectives for ProSomnus' shares. Their OSA share price targets range from $1.00 to $4.00. On average, they expect the company's share price to reach $2.33 in the next year. This suggests a possible upside of 8,384.8% from the stock's current price. View analysts price targets for OSA or view top-rated stocks among Wall Street analysts. This page (NASDAQ:OSA) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersNext President (Not Trump. Not Biden.)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredBill Gates is all about this tiny $2 stockWhat does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthles...Timothy Sykes | SponsoredProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s...Weiss Ratings | SponsoredWarren Buffett & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredWhat Nvidia insiders don’t want you to knowIf you missed out on Nvidia, don't worry. A 244-year-old pattern is about to trigger a $25.6 trillion AI surge...Behind the Markets | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProSomnus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProSomnus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.